Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.01
-0.07 (-0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
36.27
-0.74 (-2.00%)
After-hours: Mar 9, 2026, 6:35 PM EDT
Cogent Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,961 | 5,404 | 862 | 506 | 808 | 342 | |
| Market Cap Growth | 567.00% | 527.16% | 70.14% | -37.32% | 136.30% | -2.42% | |
| Enterprise Value | 5,299 | 5,181 | 644 | 273 | 605 | 228 | |
| Last Close Price | 37.01 | 35.52 | 7.80 | 5.88 | 11.56 | 8.58 | |
| PB Ratio | 10.90 | 8.49 | 3.36 | 1.96 | 3.16 | 1.60 | |
| P/TBV Ratio | 10.90 | 9.88 | 5.91 | 2.56 | 4.26 | 2.66 | |
| Debt / Equity Ratio | 0.38 | 0.38 | 0.07 | 0.07 | 0.08 | 0.02 | |
| Net Debt / Equity Ratio | -1.04 | -1.04 | -1.05 | -0.99 | -0.94 | -1.01 | |
| Net Debt / EBITDA Ratio | 2.00 | 2.00 | 0.99 | 1.24 | 1.63 | 2.87 | |
| Net Debt / FCF Ratio | 2.49 | 2.49 | 1.29 | 1.63 | 1.91 | 3.58 | |
| Quick Ratio | 14.09 | 14.09 | 5.15 | 6.96 | 9.66 | 12.86 | |
| Current Ratio | 14.24 | 14.24 | 5.32 | 7.09 | 9.87 | 13.04 | |
| Return on Equity (ROE) | -73.70% | -73.70% | -99.54% | -74.94% | -59.69% | -32.20% | |
| Return on Assets (ROA) | -32.93% | -32.93% | -53.78% | -42.35% | -34.68% | -19.55% | |
| Return on Capital Employed (ROCE) | -38.20% | -38.20% | -101.40% | -75.60% | -54.00% | -35.10% | |
| Earnings Yield | -5.52% | -6.09% | -29.70% | -38.00% | -17.36% | -21.14% | |
| FCF Yield | -4.46% | -4.92% | -24.18% | -30.89% | -15.53% | -17.69% | |
| Buyback Yield / Dilution | -24.09% | -24.09% | -30.48% | -35.41% | -51.89% | -249.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.